{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:14:18Z","timestamp":1778588058502,"version":"3.51.4"},"reference-count":90,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIA"],"DOI":"10.2147\/cia.s585263","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:35:48Z","timestamp":1778585748000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Landscape of Early Symptomatic Alzheimer\u2019s Disease Translated into Everyday Practice for Geriatric Providers"],"prefix":"10.2147","volume":"Volume 21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2732-9175","authenticated-orcid":true,"given":"Melissa","family":"Bailey-Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5367-7409","authenticated-orcid":true,"given":"Katherine","family":"Galluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnosh","family":"Sharafsaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref1","unstructured":"Alzheimer\u2019s Association. 2025 Alzheimer\u2019s disease: facts and figures. 2025. Available from: https:\/\/www.alz.org\/getmedia\/ef8f48f9-ad36-48ea-87f9-b74034635c1e\/alzheimers-facts-and-figures.pdf. Accessed July 09, 2025."},{"key":"ref2","unstructured":"WHO. Dementia. 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia. Accessed July 09, 2025."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1399121","DOI":"10.3389\/fphar.2024.1399121","volume":"15","author":"Kim","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/alz.12362","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e230009","DOI":"10.1148\/rg.230009","volume":"43","author":"Agarwal","year":"2023","journal-title":"Radiographics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"ref10","unstructured":"FDA. Early Alzheimer\u2019s disease: developing drugs for treatment guidance for industry. 2024. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/early-alzheimers-disease-developing-drugs-treatment?trk=public_post_comment-text. Accessed March 31, 2026."},{"key":"ref11","unstructured":"National Collaborating Centre for Mental Health. National institute for health and care excellence: guidelines. In: Dementia: A NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care. Leicester (UK): British Psychological Society (UK) Copyright \u00a9 2007, The British Psychological Society & The Royal College of Psychiatrists; 2007."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.14283\/jpad.2021.23","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"592302","DOI":"10.3389\/fneur.2020.592302","volume":"11","author":"Galvin","year":"2020","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/gerona\/glab043","volume":"76","author":"Qian","year":"2021","journal-title":"J Gerontol a Biol Sci Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"ref16","unstructured":"FDA. LEQEMBI\u00ae (lecanemab-irmb) injection, for intravenous use. 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761269s005lbl.pdf. Accessed March 23, 2026."},{"key":"ref17","unstructured":"FDA. KISUNLA (donanemab-azbt) injection, for intravenous use 2024. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761248s004lbl.pdf. Accessed March 31, 2026."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/15500594211042708","volume":"54","author":"Bradfield","year":"2023","journal-title":"Clin EEG Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.gerinurse.2024.07.005","volume":"59","author":"Yu","year":"2024","journal-title":"Geriatr Nurs"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u20132081. doi:10.1111\/jgs.18372","DOI":"10.1111\/jgs.18372"},{"key":"ref21","volume-title":"Diagnosis and Treatment of Clinical Alzheimer\u2019s-Type Dementia: A Systematic Review","year":"2020"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1532-5415.1989.tb02266.x","volume":"37","author":"Burke","year":"1989","journal-title":"J Am Geriatr Soc"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e12107","DOI":"10.1002\/dad2.12107","volume":"12","author":"Thompson","year":"2020","journal-title":"Alzheimers Dement"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.JGP.0000221510.33817.86","volume":"14","author":"Tariq","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/WAD.0b013e3181b03277","volume":"24","author":"Scharre","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/ageing\/afs008","volume":"41","author":"Malek-Ahmadi","year":"2012","journal-title":"Age Ageing"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/13651500802684500","volume":"13","author":"Hancock","year":"2009","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000338232","volume":"33","author":"de Rotrou","year":"2012","journal-title":"Dement Geriatr Cognit Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e0322554","DOI":"10.1371\/journal.pone.0322554","volume":"20","author":"Barakat","year":"2025","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e70060","DOI":"10.1111\/cns.70060","volume":"30","author":"Dong","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2024.13855","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","volume":"72","author":"Curtis","year":"2015","journal-title":"JAMA Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"Wong","year":"2010","journal-title":"J Nucl Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"Sabri","year":"2015","journal-title":"Alzheimers Dement"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2967\/jnumed.121.262239","volume":"63","author":"Teipel","year":"2022","journal-title":"J Nucl Med"},{"key":"ref39","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2021: journey through the diagnosis of dementia. 2021. Available from: https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2021\/. Accessed July 09, 2025."},{"key":"ref40","unstructured":"ALZFORUM. FDA approves Fujirebio\u2019s CSF test for AD\u2014Quest Diagnostic offers plasma test. 2022. Available from: https:\/\/www.alzforum.org\/news\/community-news\/fda-approves-fujirebios-csf-test-ad-quest-diagnostic-offers-plasma-test. Accessed July 09, 2025."},{"key":"ref41","unstructured":"ALZFORUM. FDA clears Roche\u2019s CSF A\u03b242\/tTau assay. 2023. Available from: https:\/\/www.alzforum.org\/news\/research-news\/fda-clears-roches-csf-av42ttau-assay. Accessed July 09, 2025."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jalz.2018.07.220","volume":"14","author":"Shaw","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1016\/j.jalz.2013.01.002","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3390\/ijms26051935","volume":"26","author":"Pokrzyk","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat Med"},{"key":"ref46","first-page":"20240703","volume":"20","author":"Schindler","year":"2024","journal-title":"medRxiv"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1212\/WNL.0000000000205835","volume":"102","author":"Chenna","year":"2024","journal-title":"Neurology"},{"key":"ref48","unstructured":"FDA. FDA clears first blood test used in diagnosing Alzheimer\u2019s disease. 2025. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease?utm_medium=email&utm_source=govdelivery. Accessed July 09, 2025."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s11606-023-08583-9","volume":"39","author":"O\u2019Brien","year":"2024","journal-title":"J Gen Intern Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"100035","DOI":"10.1016\/j.tjpad.2024.100035","volume":"12","author":"Cox","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3233\/ADR-230108","volume":"8","author":"Moore","year":"2024","journal-title":"J Alzheimers Dis Rep"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3637954","DOI":"10.1155\/2019\/3637954","volume":"2019","author":"Judge","year":"2019","journal-title":"Int J Alzheimers Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s43587-023-00400-6","volume":"3","author":"Schindler","year":"2023","journal-title":"Nat Aging"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40120-022-00416-x","volume":"12","author":"Li","year":"2023","journal-title":"Neurol Ther"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"S537","DOI":"10.3233\/JAD-240418","volume":"101","author":"Wang","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e0280471","DOI":"10.1371\/journal.pone.0280471","volume":"18","author":"Shafighi","year":"2023","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e66942","DOI":"10.7759\/cureus.66942","volume":"16","author":"Maldonado-Puebla","year":"2024","journal-title":"Cureus"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1038\/s41598-023-32878-w","volume":"13","author":"Audronyte","year":"2023","journal-title":"Sci Rep"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1038\/s41598-024-54322-3","volume":"14","author":"Igeta","year":"2024","journal-title":"Sci Rep"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jama.2025.12923","volume":"334","author":"Baker","year":"2025","journal-title":"JAMA"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e70556","DOI":"10.1002\/alz.70556","volume":"21","author":"Carrillo","year":"2025","journal-title":"Alzheimers Dement"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/alz.12035","volume":"16","author":"Herring","year":"2020","journal-title":"Alzheimers Dement"},{"key":"ref64","unstructured":"FDA. BELSOMRA\u00ae (suvorexant) tablets, for oral use [prescribing information]. 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/204569s000lbledt.pdf. Accessed March 31, 2026."},{"key":"ref65","unstructured":"FDA. FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer\u2019s disease 2023. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-treat-agitation-symptoms-associated-dementia-due-alzheimers-disease. Accessed March 31, 2026."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"ref67","unstructured":"FDA. EXELON\u00ae (rivastigmine tartrate) capsules, for oral use; EXELON\u00ae (rivastigmine tartrate) oral solution [prescribing information]. 2000. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020823s035,021025s023lbl.pdf. Accessed March 31, 2026."},{"key":"ref68","unstructured":"FDA. RAZADYNE\u00ae ER (galantamine hydrobromide) extended-release capsules, for oral use; RAZADYNE\u00ae (galantamine hydrobromide) tablets, for oral use; RAZADYNE\u00ae (galantamine hydrobromide) oral solution [prescribing information]. 2001. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021169orig1s032,021224orig1s030,021615orig1s023lbl.pdf. Accessed March 31, 2026."},{"key":"ref69","unstructured":"FDA. ARICEPT\u00ae (donepezil hydrochloride) tablets [prescribing information]. 1996 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020690s035,021720s008,022568s005lbl.pdf. Accessed March 31, 2026."},{"key":"ref70","unstructured":"FDA. NAMENDA\u00ae (memantine hydrochloride) tablets, for oral use [prescribing information]. 2003. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021487s025lbl.pdf. Accessed March 31, 2026."},{"key":"ref71","unstructured":"FDA. NAMZARIC (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use [prescribing information]. 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/206439lbl.pdf. Accessed March 31, 2026."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2214\/AJR.22.28461","volume":"220","author":"Roytman","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"20231027","DOI":"10.3390\/jcm12216792","volume":"12","author":"Sin","year":"2023","journal-title":"J Clin Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"20221222","DOI":"10.3390\/healthcare11010032","volume":"11","author":"Rashad","year":"2022","journal-title":"Healthcare"},{"key":"ref76","unstructured":"FDA. KISUNLA (donanemab-azbt) injection, for intravenous use [prescribing information]. 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761248s004lbl.pdf. Accessed March 31, 2026."},{"key":"ref77","unstructured":"FDA. KISUNLA (donanemab-azbt) injection, for intravenous use [prescribing information]. 2024a."},{"key":"ref78","unstructured":"FDA. LEQEMBI\u00ae (lecanemab-irmb) injection, for intravenous use [prescribing information]. 2023a. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761269s005lbl.pdf. Accessed March 31, 2026."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"20240222","DOI":"10.3390\/jcm13051245","volume":"13","author":"Bilodeau","year":"2024","journal-title":"J Clin Med"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/STROKEAHA.121.036873","volume":"53","author":"Sveikata","year":"2022","journal-title":"Stroke"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"595","DOI":"10.14283\/jpad.2023.50","volume":"10","author":"Dickson","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"e70062","DOI":"10.1002\/alz.70062","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(22)02480-1","volume":"400","author":"The Lancet","year":"2022","journal-title":"Lancet"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13195-024-01412-z","volume":"16","author":"Tarawneh","year":"2024","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"ref85","unstructured":"Medicare Coverage Database. Beta amyloid positron emission tomography in dementia and neurodegenerative disease. 2023. Available from: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncacal-decision-memo.aspx?proposed=N&ncaid=308. Accessed July 09, 2025."},{"key":"ref86","unstructured":"Agency for Healthcare Research and Quality. Care coordination measures atlas update. What is care coordination? 2014. Available from: https:\/\/www.ahrq.gov\/ncepcr\/care\/coordination\/atlas\/chapter2.html. Accessed July 09, 2025."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12909-023-04355-5","volume":"23","author":"Williams","year":"2023","journal-title":"BMC Med Educ"},{"key":"ref88","unstructured":"Alzheimer\u2019s Association. 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Association. 2024. Available from: https:\/\/www.alz.org\/media\/documents\/alzheimers-facts-and-figures.pdf. Accessed July 09, 2025."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"8162","DOI":"10.1002\/alz.14199","volume":"20","author":"Rentz","year":"2024","journal-title":"Alzheimers Dement"},{"key":"ref90","unstructured":"Centers for Medicare & Medicaid Services. Monoclonal antibodies directed against amyloid for the treatment of Alzheimer\u2019s disease (NCD 200.3). 2022. Available from: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncd.aspx?ncdid=375. Accessed March 26, 2026."}],"container-title":["Clinical Interventions in Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/115082","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/115082","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:36:25Z","timestamp":1778585785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/therapeutic-landscape-of-early-symptomatic-alzheimers-disease-translat-peer-reviewed-fulltext-article-CIA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":90,"URL":"https:\/\/doi.org\/10.2147\/cia.s585263","relation":{},"ISSN":["1178-1998"],"issn-type":[{"value":"1178-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}